slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,117
Current window 26,491-26,520
Pages 1,371
Rows per page 30
Component
26,491-26,520 of 41,117
03
Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
04
Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
10
Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slidesBausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations Beat · Satisfaction1 hit
18
Includes adjustments for exchange rates, divestitures, and discontinuations.Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
19
Includes non-GAAP reconciliation disclosure.Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
02
BenevolentAI | Investor Presentation Deck | 19 slidesBenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations 1 hit
02
Bigbear AI | Investor Conference Presentation Deck | 21 slidesBigbear AI | Investor Conference Presentation Deck | 21 slides · BigBear.ai
Conference presentation Investor relations 1 hit
19
Bigbear AI | Investor Conference Presentation Deck | 21 slidesBigbear AI | Investor Conference Presentation Deck | 21 slides · BigBear.ai
Conference presentation Investor relations 1 hit
02
Bigbear AI | Investor Presentation Deck | 21 slidesBigbear AI | Investor Presentation Deck | 21 slides · BigBear.ai
Pitch deck Investor relations 1 hit
19
Bigbear AI | Investor Presentation Deck | 21 slidesBigbear AI | Investor Presentation Deck | 21 slides · BigBear.ai
Pitch deck Investor relations 1 hit
02
BioAtla | Investor Conference Presentation Deck | 15 slidesBioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations 1 hit
08
The slide uses a tree-like structure to map study arms to specific patient cohorts and their corresponding interim outcomes.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
02
Bionomics | Investor Presentation Deck | 16 slidesBionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
03
The slide uses a list-based layout to summarize key company milestones and strategic pillars.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
07
The slide uses a checkmark/cross matrix to highlight the competitive advantage of BNC210.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide highlights both financial traction (milestones) and clinical progress (Phase 1 trials).Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
13
The slide presents clinical trial data showing the efficacy of MDMA-assisted therapy compared to placebo, followed by the strategic rationale for a partnership.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
02
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
03
This is a standard pharmaceutical regulatory disclosure slide.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
33
The slide uses a matrix-like table to show the application of different mRNA technologies across a portfolio of infectious disease programs.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
64
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
93
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
98
Includes process flow, flow cytometry data, and scatter plot of TCR frequency.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
100
Clinical trial design diagram showing patient flow, randomization, and treatment arms.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
102
The slide uses a process flow diagram to illustrate the clinical trial patient journey from screening to randomization and treatment arms.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
103
The slide uses a timeline diagram to show the treatment protocol and lists to summarize clinical context.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
105
Shows stacked bar chart of neoantigen immunogenicity and a line chart of IFNy spots over time for responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
109
Includes a citation to a Nature article and specific trial results (Lipo-MERIT).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
110
The chart is a 'spider plot' or 'spaghetti plot' tracking individual patient lesion kinetics.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
111
The chart displays individual patient responses, categorized by treatment type and dose, with markers for partial response (PR) and stable disease (SD/irSD).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit